Graham Capital Management’s West Pharmaceutical WST Stock Holding History

Graham Capital Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$644K	Buy	+1,794	New	+$548K	0.01%	625
2026 Q1	–	Sell	-5,347	Closed	-$1.47M	–	1548
2025 Q4	$1.47M	Buy	5,347 +1,544	+41%	+$422K	0.04%	299
2025 Q3	$998K	Buy	+3,803	New	+$924K	0.02%	385
2023 Q3	–	Sell	-886	Closed	-$339K	–	1317
2023 Q2	$339K	Buy	+886	New	+$317K	0.01%	645
2022 Q2	–	Sell	-521	Closed	-$213K	–	1270
2022 Q1	$213K	Buy	+521	New	+$204K	0.01%	819

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Graham Capital Management's WST Position: Q2 2026 in Review

Graham Capital Management opened a new position in West Pharmaceutical (WST) in Q2 2026: 1,794 shares worth $644K. The stake represents 0.01% of the portfolio and ranks #625 among its holdings. This is a return to the name: Graham Capital Management previously reported a position in WST as recently as Q4 2025.

Graham Capital Management first reported a position in WST in Q1 2022 and has held it in 5 quarters since. The position peaked at $1.47M in Q4 2025. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Graham Capital Management held 1,794 shares of West Pharmaceutical worth $644K as of Q2 2026.
West Pharmaceutical was a new Graham Capital Management position in Q2 2026.
West Pharmaceutical made up 0.01% of Graham Capital Management's portfolio in Q2 2026, its #625 holding.
Graham Capital Management first reported a position in West Pharmaceutical in Q1 2022 and has held it in 5 quarters since.
Graham Capital Management's West Pharmaceutical position peaked at $1.47M in Q4 2025.
834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.